JP2020534284A5 - - Google Patents

Download PDF

Info

Publication number
JP2020534284A5
JP2020534284A5 JP2020515680A JP2020515680A JP2020534284A5 JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5 JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020515680 A JP2020515680 A JP 2020515680A JP 2020534284 A5 JP2020534284 A5 JP 2020534284A5
Authority
JP
Japan
Prior art keywords
protein
composition according
rsv
composition
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020515680A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020534284A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/051054 external-priority patent/WO2019055768A1/en
Publication of JP2020534284A publication Critical patent/JP2020534284A/ja
Publication of JP2020534284A5 publication Critical patent/JP2020534284A5/ja
Pending legal-status Critical Current

Links

JP2020515680A 2017-09-15 2018-09-14 ワクチン、並びに、呼吸器合胞体ウイルス(rsv)感染症を予防するためのワクチンの作製方法及び使用方法 Pending JP2020534284A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762559167P 2017-09-15 2017-09-15
US62/559,167 2017-09-15
PCT/US2018/051054 WO2019055768A1 (en) 2017-09-15 2018-09-14 VACCINES AND METHODS OF MAKING AND USING VACCINES FOR THE PREVENTION OF SYNCYTIAL RESPIRATORY VIRUS (RSV) INFECTIONS

Publications (2)

Publication Number Publication Date
JP2020534284A JP2020534284A (ja) 2020-11-26
JP2020534284A5 true JP2020534284A5 (enExample) 2021-10-21

Family

ID=65723867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020515680A Pending JP2020534284A (ja) 2017-09-15 2018-09-14 ワクチン、並びに、呼吸器合胞体ウイルス(rsv)感染症を予防するためのワクチンの作製方法及び使用方法

Country Status (8)

Country Link
US (1) US20200276297A1 (enExample)
EP (1) EP3681523A4 (enExample)
JP (1) JP2020534284A (enExample)
KR (1) KR20200096904A (enExample)
CN (1) CN111344008A (enExample)
AU (1) AU2018331467A1 (enExample)
CA (1) CA3075990A1 (enExample)
WO (1) WO2019055768A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3946446A1 (en) * 2019-04-02 2022-02-09 Sanofi Antigenic multimeric respiratory syncytial virus polypeptides
CN112226450B (zh) * 2020-08-25 2022-10-14 北京交通大学 一种共表达呼吸道合胞病毒融合前蛋白和黏附糖蛋白的复制缺陷型腺病毒载体疫苗
US20250127872A1 (en) * 2021-09-29 2025-04-24 Sk Bioscience Co., Ltd. Recombinant live attenuated rsv vaccine strain and production method therefor
KR102806300B1 (ko) * 2023-01-13 2025-05-14 클립스비엔씨 주식회사 호흡기 신시치아 바이러스 변이체를 포함하는 호흡기 신시치아 바이러스 백신용 융합단백질 및 이의 제조방법
CN118930654A (zh) * 2023-05-12 2024-11-12 中国科学院微生物研究所 一种呼吸道合胞病毒抗原制备方法和应用
CN117720628A (zh) * 2023-10-12 2024-03-19 中国科学院微生物研究所 一种呼吸道合胞病毒二价抗原制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1224462A (zh) * 1996-07-15 1999-07-28 美国政府健康及人类服务部 从克隆的核苷酸序列制备减毒呼吸道合胞病毒疫苗的方法
BR0011159A (pt) * 1999-04-13 2002-07-23 Government Of The Us Dept Of H Método para produzir vacinas de vìrus rna de fita negativa atenuado a partir de sequências de nucleotìdeos clonados
AU2001264824A1 (en) * 2000-06-01 2001-12-11 St. Jude Children's Research Hospital Vaccine and gene therapy vector and methods of use thereof
AU2002327755A1 (en) * 2001-09-28 2003-04-14 Rush-Presbyterian-St. Luke's Medical Center Paramyxoviruses as gene transfer vectors to lung cells
CA2477235A1 (en) * 2002-02-21 2003-09-04 Medimmune Vaccines, Inc. Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
DE60330966D1 (de) * 2002-07-26 2010-03-04 Canada Natural Resources Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber
KR100999316B1 (ko) * 2003-06-09 2010-12-10 와이어쓰 엘엘씨 cDNA로부터의 비분절 네가티브 쇄 RNA 바이러스의회수를 위한 개선된 방법
ATE555208T1 (de) * 2003-06-13 2012-05-15 Apath Llc Replikon eines negativsträngigen rna-virus
US8287878B2 (en) * 2004-04-09 2012-10-16 Wyeth Llc Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
WO2008133663A2 (en) * 2006-11-30 2008-11-06 Government Of The United States Of America, As Represented By The Secretary, Codon modified immunogenic compositions and methods of use
WO2009025770A2 (en) * 2007-08-17 2009-02-26 Wyeth A heterologous prime-boost immunization regimen
US20090162321A1 (en) * 2007-12-20 2009-06-25 Wyeth Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein
RU2011122615A (ru) * 2008-11-05 2012-12-20 Мерк Шарп Энд Домэ Корп. Живой аттенуированный респираторно-синцитиальный вирус
KR102416194B1 (ko) * 2014-03-01 2022-07-04 프로펙츄스 바이오사이언스, 인크. 재조합 이스파한 바이러스 벡터
CN106659777A (zh) * 2014-06-13 2017-05-10 葛兰素史密丝克莱恩生物有限公司 免疫原性组合产品

Similar Documents

Publication Publication Date Title
JP2020534284A5 (enExample)
JP2020022459A5 (enExample)
JP2019530462A5 (enExample)
MY193584A (en) Vaccine against rsv
JP2015096070A5 (enExample)
JP2017048194A5 (enExample)
JP2018520997A5 (enExample)
IL288541B (en) Vaccine against rsv
JP2013507907A5 (enExample)
ATE419369T1 (de) Chimäre mensch-rinder respiratory syncytial virus vakzinen
JP2016506416A5 (enExample)
JP2016146837A5 (enExample)
JP2014502156A5 (enExample)
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
JP2019146574A5 (enExample)
JP2015533841A5 (enExample)
JP2016052331A5 (enExample)
JP2014507146A5 (enExample)
JP2015501840A5 (enExample)
JP2012511579A5 (enExample)
JP2015529678A5 (enExample)
RU2013120979A (ru) Северо-американский вирус репродуктивно-респираторного синдрома свиней (prrs) и его применения
JP2010508030A5 (enExample)
JP2017514522A5 (enExample)
JP2013502225A5 (enExample)